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Summary: The decrease in the increase in death rates at old ages is a phenomenon that
has repeatedly been discussed in demographic research. While mortality deceleration can
be explained in the gamma-Gompertz model as an effect of selection in heterogeneous
populations, this phenomenon can be difficult to assess statistically because it relates to
the tail of the distribution of the ages at death. By using a focused information criterion
(FIC) for model selection, we can directly target model performance at those advanced
ages. The gamma-Gompertz model is reduced to the competing Gompertz model without
mortality deceleration if the variance parameter lies on the boundary of the parameter
space. We develop a new version of the FIC that is adapted to this non-standard condition.
In a simulation study, the new FIC is shown to outperform other methods in detecting
mortality deceleration. The application of the FIC to extinct French-Canadian birth
cohorts demonstrates that focused model selection can be used to rebut previous assertions
about mortality deceleration.
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1 Introduction
The tendency for the death rates of human adults to increase exponentially with age
is an empirical regularity that has been known at least since Gompertz (1825). More
recently, however, as vital statistics have improved and more detailed information has
become available for individuals who survive to very old ages, a downward deviation from
the exponential hazard has been observed at advanced ages, and new mortality models
for the oldest-old have been proposed (Thatcher et al., 1998; Thatcher, 1999; Bebbington
et al., 2014). This slowdown in the death rates at old ages is a phenomenon commonly
known as mortality deceleration.
Theoretically, such a deceleration is expected to occur if birth cohort members have
heterogeneous mortality risks (Beard, 1959). As a result of selection, frail individuals with
higher mortality levels tend to die at younger ages, while the more robust individuals
with lower death risks tend to survive to higher ages. This heterogeneity hypothesis has
been supported empirically for human (and non-human) populations by a large number
of studies (among others Vaupel et al., 1979; Horiuchi and Wilmoth, 1998; Lynch and
Brown, 2001). However, the phenomenon of mortality deceleration has also been contested
(Gavrilov and Gavrilova, 2011; Gavrilova and Gavrilov, 2015).
Accurately describing the age trajectory of mortality at advanced ages is of interest to
demographers and ageing researchers because it provides insights into the potential limits
of human longevity (Rootzén and Zholud, 2017). However, mortality deceleration also has
important implications for life insurance and public health.
As mortality deceleration occurs in the tail of the survival distribution, where data
are unavoidably scarce, the statistical assessment of this phenomenon is challenging, and
standard methods may fail to identify deviations from the Gompertz hazard for the very
old. For example, Figure 1 shows for French-Canadians born between 1880 and 1896 the
empirical death rates by age at ages 90 and above, as well as the number of deaths at each
age. We can see that 75% of all deaths in this population had already occurred by age 96
for women and by age 95 for men.
Moreover, the apparent slowdown in death rates with advancing age has repeatedly been
attributed to data of questionable quality. Exaggeration in the reporting of age and the
failure to remove deceased individuals from registers (due to unreported deaths) can result
in an overestimation of the number of long-lived individuals, which will bias death rates
downward. Thus, for individuals who die at very old ages, a thorough scientific validation
of the reported age at death is mandatory (Jeune and Vaupel, 1999). The need for age
validation may, however, limit data availability. Here, we will analyse a set of high-quality
mortality data for French-Canadians born in Quebec at the end of the 19th century. These
data include nominative information that is deemed confidential, but that is needed when
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Figure 1: Top: Death rates (on log scale) with 95% confidence intervals for French-
Canadian females (left) and males (right). Bottom: Frequency distribution of
ages at death.
carrying out a rigorous age validation protocol. At the time of writing, we were granted
access to data only on individuals who had lived past the age of 90. Furthermore, adding
the deaths of individuals aged 85-89 or 80-89 to the data set would have substantially
increased the number of cases to be validated. Such restrictions will make the analysis
considerably more demanding, as we will show.
In this paper, we will discuss the statistical assessment of mortality deceleration in
the framework of the gamma-Gompertz model. This model belongs to the class of pro-
portional hazards frailty models, which provide the standard approach for formalising the
heterogeneity hypothesis (Vaupel et al., 1979; Wienke, 2011). A Gompertz baseline hazard
is multiplied by a gamma-distributed random effect (the frailty). The variance parame-
ter of the gamma frailty describes the heterogeneity in the risk of death. If it takes a
positive value, the individually heterogeneous hazards will result in a population hazard
that shows a downward deviation from the exponentially increasing Gompertz hazard at
advanced ages. If the variance parameter takes the value of zero, the population hazard is
exponentially increasing; that is, the model is simplified to the Gompertz model. Thus, an-
swering the question of whether mortality does or does not decelerate at advanced ages in
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this setting corresponds to selecting the gamma-Gompertz model or the Gompertz model.
However, the single additional parameter of the gamma-Gompertz model – namely, the
variance parameter – lies on the boundary of the parameter space if the true model is
the Gompertz model. As this boundary constraint on the parameter violates the usual
regularity assumptions, the inference and the model selection have to be adapted to this
non-standard condition.
We propose using a focused information criterion (FIC, Claeskens and Hjort, 2003) to
assess mortality deceleration. While other information criteria, like the Akaike information
criterion (AIC, Akaike, 1974), select a ‘best’ model regardless of the specific estimand that
is of interest; the FIC selects the model that performs ‘best’ for a specific parameter of
interest, called the focus parameter. Applying the FIC is particularly appealing in our
application, as it will allow us to choose a focus parameter that is directly affected by the
presence or absence of mortality deceleration; for example, the hazard at some advanced
age. Technically, the FIC is constructed as an unbiased estimator of the limiting risk of an
estimator of the focus parameter, and the candidate model with the smallest FIC value is
selected. While the standard version of the FIC aims to minimise the mean squared error
(MSE) of the estimator of the focus parameter, the criterion has been generalised to other
risk measures, such as Lp-risks (Claeskens et al., 2006). Still, all of these model selection
criteria have been developed based on general likelihood theory under the standard regu-
larity assumptions, which are violated in our setting. Therefore, we will derive versions of
the FIC that allow us to choose between two models in which the additional parameter
may lie on the boundary of the parameter space.
The paper is structured as follows. In Section 2, we first introduce the gamma-Gompertz
model, and present traditional methods for detecting mortality deceleration in this frame-
work. Then, in Section 3, we propose the FIC as a new approach for assessing this phe-
nomenon. In Section 4, we investigate the performance of the FIC in a simulation study,
and compare it with the performance of an AIC that is adjusted to the presence of the
boundary constraint. We apply the new model selection criteria to the French-Canadian
data in Section 5, and we conclude with a discussion in Section 6.
2 Mortality deceleration: Model and traditional approaches
2.1 Gamma-Gompertz model
To model adult lifespans (typically above age 30), we consider the continuous random
variable Y . Its distribution can be characterised by the hazard function
h(y) = lim
∆y↘0
= P (y < Y ≤ y + ∆y|Y > y)∆y .
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The standard approach to modelling individually heterogeneous hazards is via proportional
hazards frailty models of the form h(y|Z = z) = z · h0(y). Here, a positive random
effect Z (called frailty) acts multiplicatively on a common baseline hazard h0(y), such
that h(y|Z = z) denotes the conditional hazard of an individual at age y, given that his or
her frailty is Z = z. The frailty Z is often assumed to follow a gamma distribution with
mean one and variance σ2. The choice of the gamma distribution is both mathematically
convenient and theoretically justified. Abbring and van den Berg (2007) proved that the
distribution of the heterogeneity among survivors converges to a gamma distribution for a
large class of proportional hazards frailty models. The so-called gamma-Gompertz model
is obtained if the gamma frailty is multiplied to an exponentially increasing Gompertz
baseline hazard, h0(y) = aeby with the parameters a > 0 and b > 0.
The variance parameter σ2 of the gamma-Gompertz model describes the heterogeneity
of frailty. If σ2 > 0, there is heterogeneity in the risk of death, and the selection of more
robust individuals will take place. As a consequence, the resulting marginal hazard,
h(y) = ae
by
1 + σ2 ab (eby − 1)
, (1)
shows a deceleration at advanced ages. If σ2 = 0, there is no heterogeneity and the
marginal hazard is exponentially increasing, such that h(y) = aeby. Hence, in the frame-
work of the gamma-Gompertz model, the statistical assessment of mortality deceleration
is reduced to inference on the parameter σ2.
It is important to note that the parameter σ2 measures population heterogeneity at
the starting age of the model (corresponding to y = 0). Due to the continuing selection
of robust individuals, the variance of frailty among the survivors decreases with age.
Thus, the higher the age at which we start our observation, the lower the heterogeneity
in mortality is among the individuals in the sample. The age at the beginning of the
observation will, therefore, have an impact on the resulting inference.
The inference in the gamma-Gompertz model involves the frailty variance σ2, which
is a parameter that lies on the boundary of its parameter space in the absence of mor-
tality deceleration (σ2 = 0). This violates the standard assumptions that underlie the
asymptotic properties of the likelihood-based inference, which in turn affects the tradi-
tional approaches for assessing mortality deceleration that are presented in the following
section.
2.2 Traditional approaches
Two methods are commonly used for assessing mortality deceleration in the framework of
the gamma-Gompertz model: a likelihood ratio test for a zero frailty variance, and model
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selection between the gamma-Gompertz model and the Gompertz model based on the
AIC.
The likelihood ratio test for homogeneity in the gamma-Gompertz model, where H0 :
σ2 = 0 and H1 : σ2 > 0, is non-standard in that, under the null hypothesis, the pa-
rameter σ2 lies on the boundary of the parameter space. Consequently, the asymptotic
distribution of the likelihood ratio test statistic under H0 is no longer a chi-squared dis-
tribution with one degree of freedom. However, using the results of Self and Liang (1987),
it can be shown that under the null hypothesis, the likelihood ratio test statistic asymp-
totically follows a 50:50 mixture of a point mass at zero and a chi-squared distribution
with one degree of freedom, 12χ20 +
1
2χ
2
1. Tests based on the wrong assumption of a χ21-
distribution of the test statistic occasionally appear in studies of mortality deceleration
(Pletcher, 1999). Ignoring the issue of the boundary parameter and using the incorrect
distribution of the test statistic lowers the power to (correctly) decide in favour of the
gamma-Gompertz model. But even when the test statistic is correctly assumed to follow
a 12χ20 +
1
2χ
2
1-distribution, the likelihood ratio test has low power to detect mortality decel-
eration in the gamma-Gompertz model. This is especially likely to be the case when the
inference has to be based on age-restricted samples, such as a sample of individuals who
survived beyond age 90 (see Section S.2 of the supplementary material for an illustration).
A popular alternative approach for assessing mortality deceleration is model selection
based on the AIC (Richards, 2008; Gavrilova and Gavrilov, 2015). The AIC targets an
unbiased estimate of the Akaike information; that is, of the expected relative Kullback-
Leibler distance between the true data-generating mechanism and the best parametric
approximation. Under standard conditions, the AIC is therefore defined as −2ü + 2k,
where the log-likelihood ü, evaluated at the maximum likelihood estimate, is penalised by
the number k of parameters in the model. This common definition has, however, been
found to be biased under the non-standard conditions of the gamma-Gompertz model
(Böhnstedt and Gampe, 2019). Thus, the standard version of the AIC is not a valid tool
for model selection in the setting of the gamma-Gompertz model. In Section 3.4, we will
present a modified version of the AIC that is adjusted to the presence of a boundary
parameter.
3 Focused information criterion for mortality deceleration
The preceding considerations indicate that neither a testing strategy, particularly if it is
low-powered, nor an all-purpose model selection criterion will adequately assess the occur-
rence of mortality deceleration. Focused information criteria (FIC) have been introduced
to address problems of this kind, and we propose selecting the model based on a new
version of the FIC that takes the boundary constraint on the frailty variance into account.
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3.1 Rationale for FIC
Statistical analyses are performed for particular purposes, and acknowledging the specific
purpose when choosing the statistical model is the key concept of a FIC. In the following
exposition, we use the terminology and notation of Claeskens and Hjort (2003).
Observations yi, i = 1, . . . , n (here: ages at death) are assumed to be generated by a
parametric density f(y). The parameters of the model are split into a d-vector θ, which
characterises the narrow model, and an additional q-vector γ for the extended model. The
narrow model is obtained for one particular value γ0, which is fixed and known. In the
current application, the density of the gamma-Gompertz model (1) is
f(y) = aeby
{
1 + σ2a
b
(eby − 1)
}−(1+ 1
σ2
)
.
The parameter θ = (a, b)T is the Gompertz part of the model, so d = 2. The single
additional parameter is γ = σ2 with γ0 = 0, so q = 1.
The original FIC is derived in a framework of local misspecification (Hjort and Claeskens,
2003), where a sample of size n is assumed to be generated from a density
ftrue(y) = f(y,θ0,γ0 + δ/
√
n), (2)
with the parameter vector γ = γ0 + δ/
√
n perturbed in the direction of δ. Selection is
between the null model, where γ is fixed at the known value γ0; the full model, including
both θ and γ; and, if q > 1, any model including θ, but only a subset of the components of
γ and the remaining fixed at the respective values in γ0. For the current setting, selection
is only between the null model with σ2 = 0, that is, the Gompertz model; and the full
model including σ2, that is, the gamma-Gompertz model. Due to the boundary constraint
on the frailty variance, δ =
√
nσ2 is subject to the a priori restriction δ ≥ 0. Therefore,
we will restrict the framework in the following to the choice of including or not including
a single parameter with a boundary constraint; that is, q = 1 and γ ≥ γ0.
The focus is the parameter of interest, which depends on the underlying density (2) via
θ and γ. The focus is commonly denoted by µ, and we define µtrue = µ(θ, γ0 + δ/
√
n).
Based on the maximum likelihood estimators θˆnull in the null model and (θˆfull, γˆ) in the
full model, the focus parameter is estimated as µˆnull = µ(θˆnull, γ0) or µˆfull = µ(θˆfull, γˆ). For
each model M , M ∈ {null, full}, the estimator µˆM converges in distribution,
√
n(µˆM −
µtrue) d−→ ΛM .
The FIC selects the model that performs ‘best’ for the focus parameter µ. If it is based
on the general Lp-loss, the FIC aims to estimate without bias the limiting Lp-risk of µˆM ;
that is, rp(M) = E[|ΛM |p]. The model for which this limiting risk is smaller is selected by
the criterion. Of particular interest is a FIC based on the MSE (p = 2, as for the original
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version, Claeskens and Hjort, 2003), constructed as an estimator of E[Λ2M ]; and a FIC
based on the mean absolute error (MAE, p = 1), constructed as an estimator of E[|ΛM |].
3.2 FIC with a parameter on the boundary of the parameter space
Under standard regularity conditions, when general likelihood theory applies, the asymp-
totic normality of the maximum likelihood estimator implies that the ΛM are normally
distributed (Claeskens and Hjort, 2003). In the non-standard setting considered here, Λfull
is not normally distributed because the maximum likelihood estimator (θˆfull, γˆ) converges
in distribution to a mixture with two components (Böhnstedt and Gampe, 2019). The
limiting distribution depends on the information matrix Jfull of the full model evaluated
at the null model (θ0, γ0). We denote by J00, J01, J10, and J11, the four blocks of Jfull
corresponding to the components θ and γ of the parameter vector; and by κ2 the ele-
ment of the inverse information matrix J−1full, which corresponds to γ. Then, the following
convergence in distribution holds for the estimator of the frailty variance
√
n(γˆ − γ0) d−→ max (0, D) with D ∼ N (δ, κ2).
For the limiting distribution of the estimator of the focus parameter, it can be shown that
√
n(µˆnull − µtrue) d−→ Λnull = Λ0 + ωδ and
√
n(µˆfull − µtrue) d−→ Λfull =
Λ0 + ω(δ −D) if D > 0Λ0 + ωδ if D ≤ 0 , (3)
where Λ0 ∼ N (0, τ20 ) is independent of D, τ20 =
(
∂µ
∂θ
)T
J−100
∂µ
∂θ and ω = J10J
−1
00
∂µ
∂θ − ∂µ∂γ
(cf. Section 10.2 in Claeskens and Hjort, 2008).
To define a FIC, we need to derive E[|Λ|] or E[Λ2] from (3), depending on whether we
intend to base the criterion on the limiting L1- or L2-risk of the estimator µˆ.
As in the original version of the FIC, the limiting MSE of µˆ is considered first. However,
as we will demonstrate in the following, the FIC based on the L2-risk has some drawbacks
in the current setting, which makes the L1-risk an attractive alternative.
From equation (3) we can determine E[Λ2] for the null and the full model:
E[Λ2null] = τ20 +ω2δ2 and E[Λ2full] = τ20 +ω2
{
δ2Φ
(
− δ
κ
)
− κδφ
(
δ
κ
)
+ κ2Φ
(
δ
κ
)}
, (4)
where Φ(·) and φ(·) denote the cdf and the pdf of the standard normal distribution,
respectively. The FICMSE would be constructed as an unbiased estimator of the MSEs
in (4), and the model with the smaller FIC value would be selected.
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As has already been pointed out by Claeskens and Hjort (2008, Section 5.3), in the case
of a single additional parameter γ, the so-called tolerance radius does not depend on the
focus µ. This radius signifies the deviation δ for which the MSE of the null model estimator
is smaller than that of the full model estimator; that is, E[Λ2null] ≤ E[Λ2full]. From (4), we
see that the two risks are the same for ω = 0, and that if ω Ó= 0 the tolerance radius
encompasses all δ with δ < 0.8399κ. We can still define a pre-test strategy for assessing
mortality deceleration, which is based on the quantity δˆ/κˆ, where δˆ =
√
n(γˆ−γ0) =
√
nσˆ2
and κˆ is derived from the observed Fisher information. If δˆ/κˆ ≤ 0.8399, the estimator µˆnull
based on the Gompertz model is used; whereas if δˆ/κˆ > 0.8399, the estimator µˆfull based
on the gamma-Gompertz model is used. We note here that δˆ is not an unbiased estimator
of δ, with the bias depending in a complex way on δ and κ. In appraising this pre-test-
based model choice, we can see that for large samples, the local power of this strategy is
approximately the same as the power of a likelihood ratio test for H0 : σ2 = 0 at the 20%
level (cf. Section S.3 of the supplementary material).
Although strategies based on the limiting L2-risks of the estimator µˆ are common,
the derived pre-test strategy has drawbacks. On the one hand, the performance of this
strategy does not depend on the chosen focus parameter; while on the other, the equal
penalty for squared bias and variance of the estimators in the L2-risk might not be suitable
for choosing whether to include a heterogeneity parameter.
Consequently, using risk measures other than the L2-risk can be more appropriate, as
was already suggested in Claeskens et al. (2006). Formulas for the general limiting Lp-
risk of µˆM were derived there under regularity conditions where ΛM follows a normal
distribution for each of the models. In our non-standard setting, the limiting distribution
of the full model estimator in (3) is not normal, but we can still derive the limiting L1-risk
of the estimators µˆnull and µˆfull as follows (see Section S.4 of the supplementary material
for details):
E[|Λnull|] = 2τ0φ
(
ωδ
τ0
)
+ 2ωδ
{
Φ
(
ωδ
τ0
)
− 12
}
and
E[|Λfull|] =
[
2τ0φ
(
ωδ
τ0
)
+ 2ωδ
{
Φ
(
ωδ
τ0
)
− 12
}]{
1− Φ
(
δ
κ
)}
(5)
+
√
τ20 + ω2κ2 ·
√
2
pi
Φ
 δ
κ
·
√
τ20 + ω2κ2
τ0
− ωκφ( δ
κ
)
· 2
{
Φ
(
ωδ
τ0
)
− 12
}
.
Thus, we define the FICMAE of the null model and the full model as the estimators
FICMAE(null) = 2τˆ0φ
(
ωˆδˆ
τˆ0
)
+ 2ωˆδˆ
{
Φ
(
ωˆδˆ
τˆ0
)
− 12
}
and
FICMAE(full) =
[
2τˆ0φ
(
ωˆδˆ
τˆ0
)
+ 2ωˆδˆ
{
Φ
(
ωˆδˆ
τˆ0
)
− 12
}]{
1− Φ
(
δˆ
κˆ
)}
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+
√
τˆ20 + ωˆ2κˆ2 ·
√
2
pi
Φ
 δˆ
κˆ
·
√
τˆ20 + ωˆ2κˆ2
τˆ0
− ωˆκˆ φ( δˆ
κˆ
)
· 2
{
Φ
(
ωˆδˆ
τˆ0
)
− 12
}
,
respectively. Based on this new model selection criterion FICMAE, the full model is chosen
if the estimated MAE of its estimator of the focus parameter µ is smaller than the MAE
for the null model estimator. In contrast to the MSE, the tolerance radius determined by
the MAE of µˆM does depend on the focus parameter via ω and τ0.
3.3 Choice of the focus parameter
The central concept and virtue of the FIC approach is that it allows us to consolidate a sci-
entific question in a focus parameter, and to customise the model selection to the specific
focus. In the context of mortality deceleration, two focus parameters suggest themselves.
The first parameter is the frailty variance, since it determines whether mortality deceler-
ation is present, so µ = σ2. The second focus parameter targets the deceleration of the
hazard function, measured by the second derivative of the log-hazard at some (high) age
y so that µ = [ln h(y)]′′.
For µ = σ2 the expressions in (5) take the form
E[|Λnull|] = δ and E[|Λfull|] = κ
√
2
pi
− κφ
(
− δ
κ
)
+ δΦ
(
− δ
κ
)
.
Consequently, model choice based on the FICMAE results in the gamma-Gompertz model
if δˆ/κˆ > 0.6399. If we view this as a pre-test strategy, then it has asymptotically the same
local power as the likelihood ratio test for H0 : σ2 = 0 at a level of 26%.
If we choose µ = [ln h(y)]′′ the choice of the age y should be such that it marks an age in
the tail of the distribution where deceleration occurs, but which still lies within the range
of observed lifespans.
While the above choices of the focus parameter are natural and allow for immediate
interpretations, we could also select as the focus any function that characterises the distri-
bution of lifespans, such as the survival function or the log-hazard. The effects of different
focus parameters on the model selection will be briefly illustrated in the simulation study
in Section 4, and recommendations will be given in Section 6.
3.4 A modified AIC for the gamma-Gompertz model
As we mentioned in Section 2.2, the standard AIC is biased as an estimator of the Akaike
information in the presence of a boundary parameter, and should therefore not be used
for assessing mortality deceleration. However, Böhnstedt and Gampe (2019) explicitly
derived the bias of the standard AIC for the gamma-Gompertz model (1) under the local
misspecification framework (2) as 2 Φ (−δ/κ). This bias depends via δ = √nσ2 on the
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unknown value of the frailty variance, and it cannot be estimated without bias if the true
variance is small. Thus, the bias cannot be removed completely, but it can be reduced if
we correct the standard AIC using the estimator 2 Φ
(
−δˆ/κˆ
)
of the bias term. Hence, we
define a modified version of the AIC for the gamma-Gompertz model as
AIC∗ = −2 ü+ 2 · 3− 2 Φ
(
− δˆ
κˆ
)
. (6)
The performance of this modified AIC∗ for detecting mortality deceleration is studied in
the next section.
4 Simulation study
To examine the performance of the proposed FICMAE in assessing mortality deceleration,
we conducted a simulation study. In addition to considering different choices for the
focus, the study compares the behaviour of the FICMAE with that of the pre-test based
on L2-risks, and with that of the AIC∗ defined in (6).
The following factors will affect the performance of the different strategies: the size of
the true frailty variance σ2; the sample size n; and the starting age used when observing
lifespans, with a younger starting age being more favourable for detecting actual mortality
deceleration.
For the frailty variance (at y = 0), three different scenarios were considered: σ2 = 0.0625
(S1) and σ2 = 0.03 (S2) with Gompertz parameters a = 0.013, b = 0.092. Scenario S3
is a pure Gompertz model with a = 0.0198, b = 0.0726 (and σ2 = 0). These numbers
were inspired by the data on French-Canadian females that are analysed in the following
section.
To cover the latter two aspects, survival times were generated from the gamma-Gompertz
model (1), with y = 0 corresponding to age 60. However, the model selection was based
only on subsets of individuals reaching certain ages. Motivated by the French-Canadian
data, we considered individuals who survived to ages 90 or higher (90+). Additional com-
parisons based on the larger subsets of individuals who survived to ages 85+ and 80+ are
presented in Section S.6 of the supplementary material.
For each scenario S1 to S3, three different initial sample sizes (at age 60) were chosen,
such that the size of the 90+ subset approximately equals n90+ = 10,000 (small), n90+ =
20,000 (medium) or n90+ = 105,000 (large). The sample sizes may look unusually large,
but they cover a realistic range of population-based data. The French-Canadian data
presented in Figure 1 contain information on about 20,000 women and 10,000 men.
For each 90+ sample, the log-likelihoods for the Gompertz model and the gamma-
Gompertz model were maximised using function nlm() in R (R Core Team, 2018); further
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computational details are given in Section S.1 of the supplementary material. Then, the
best model is selected based on the FICMAE for different focus parameters, the MSE
pre-test of δ < 0.8399κ, and the AIC∗. We ran 1,000 replications for each setting.
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Figure 2: Proportion of decisions in favour of the gamma-Gompertz model. Left: Scenario
S1 for sample sizes n90+ = 10,000, n90+ = 20,000 and n90+ = 105,000 (left to
right) based on FICMAE with µ = [ln h(100)]′′ (black-solid-circle), pre-test (red-
dashed-cross) and AIC∗ (blue-dotted-triangle). Right: Scenarios S1, S2 and S3
(left to right) all with n90+ = 20,000 based on FICMAE with µ = [ln h(100)]′′
(black circle), µ = [ln h(110)]′′ (red cross) and µ = σ2 (blue triangle).
The left panel of Figure 2 compares the performance of the three selection approaches in
scenario S1 (σ2 = 0.0625) across the various sample sizes. The FICMAE with focus param-
eter µ = [ln h(100)]′′ clearly outperforms the other two methods, as it detects mortality
deceleration more often. The proportion of correct decisions in favour of the gamma-
Gompertz model increases with the sample size for all three methods, and is close to one
for the setting with a large sample size. However, for the setting with a small (medium)
sample size, the proportion of correct decisions based on the FICMAE is 82.6% (37.1%)
higher than that based on the AIC∗.
The right panel of Figure 2 illustrates the performance of the FICMAE depending on
the magnitude of the frailty variance, and on the choice of the focus parameter in the
medium sample size setting. We display the results for the focus parameters µ = σ2,
µ = [ln h(100)]′′ and µ = [ln h(110)]′′. The ability of the method to detect deviations from
the Gompertz hazard naturally decreases when the frailty variance decreases. For scenario
S2, in which the frailty variance is about half as large as it is in scenario S1, the proportion
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of correct decisions is about 35% smaller than it is for S1. If the true model is the Gompertz
model (S3), then the proportion of decisions in favour of the gamma-Gompertz model is
about 25% for the medium sample size. As the FICMAE performs equally well for all three
focus parameters, the age y at which µ = [ln h(y)]′′ is evaluated does not seem to matter.
It also turns out that the focus parameters µ = σ2 and µ = [ln h(y)]′′ perform better than,
for instance, µ = ln h(y) or µ = S(y); as is shown in Section S.5 of the supplementary
material. Although the focus age y did not affect the results in the simulation study,
other aspects may render one choice more reasonable than another. In the medium-sized
scenario S1, in which around 20,000 individuals reach age 90, more than a thousand will,
on average, also reach age 100, but fewer than 10 will reach age 110. Consequently, a focus
age of y = 100 will probably produce more reliable results than a focus age of y = 110.
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Figure 3: Left: Box plots of FICMAE values with µ = [ln h(100)]′′ for the null and the
full model in scenario S1 with n90+ = 20,000 and empirical MAE of focus esti-
mates µˆ (red-dashed). Right: Empirical MAE of selected µˆ for µ = [ln h(100)]′′
in scenario S1 for sample sizes n90+ = 10,000, n90+ = 20,000 and n90+ = 105,000
(left to right) based on FICMAE (black-solid-circle), pre-test (red-dashed-cross),
and AIC∗ (blue-dotted-triangle).
The concept of the FICMAE as an estimator of the limiting MAE of µˆ is illustrated in the
left panel of Figure 3, which shows a box plot of the FICMAE values with µ = [ln h(100)]′′
for 1,000 replications of the medium-sized scenario S1. We see that for both the null
and the full model, the empirical MAEs of the estimators µˆnull and µˆfull are close to
the average of the respective FIC scores. As a consequence, the empirical MAE of the
selected estimators in the 1,000 replications – that is, µˆfull for those replications, where
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FICMAE(full) < FICMAE(null) and µˆnull otherwise – should be smaller than it is for other
selection criteria. The right panel of Figure 3 verifies for scenario S1, that the estimator
µˆ of µ = [ln h(100)]′′ has the smallest empirical MAE when the model selection is based
on the FICMAE with µ = [ln h(100)]′′, rather than on the pre-test or the AIC∗.
Overall, the findings of the simulation study support the claim that the proposed
FICMAE is a suitable tool for detecting mortality deceleration in the framework of the
gamma-Gompertz model, which outperforms the competing approaches of the pre-test
and AIC∗.
5 Mortality of French-Canadians at high ages
As an application of the proposed methods, we analyse a highly reliable set of data on
French-Canadians that was briefly introduced in Section 1. This data set is an expanded
version of an earlier collection of verified mortality data on French-Canadian centenarians
(see Ouellette and Bourbeau (2014) and Ouellette (2016) for further details) to which the
deaths of individuals aged 90-99 were added. The data cover virtually all Catholic French-
Canadians (20,917 females and 10,878 males) who were born in the Province of Quebec
during the 1880-1896 period, and who died at ages 90 and above in Quebec between
1970 and 2009. These 1880-1896 birth cohorts were fully extinct by the end of 2009.
The exact survival times in days were obtained by linking individual death certificates to
corresponding birth registration documents taken from Quebec’s parish register archives.
We fit the gamma-Gompertz model and the Gompertz model to the female and the male
data separately via maximum likelihood. For that purpose, we set age 60 as the starting
age of the models, and take into account left truncation at age 90. Then, we choose between
the gamma-Gompertz model and the Gompertz model based on the AIC∗, pre-test and
FICMAE for the focus parameters µ = σ2 and µ = [ln h(100)]′′.
Figure 4 shows the fit of the gamma-Gompertz model and the Gompertz model, respec-
tively, to the empirical death rates (single years of age) for the French-Canadian cohorts.
The estimated frailty variance in the gamma-Gompertz model is σˆ2 = 0.043 for the female
population and σˆ2 = 0.037 for the male population. A likelihood ratio test for H0 : σ2 = 0
results in a p-value of 0.121 for females and 0.283 for males, such that the hypothesis of no
mortality deceleration would not be rejected at the usual levels of significance. Table 1 also
shows that based on the modified AIC∗, the Gompertz model is selected for both females
and males. By contrast, based on the pre-test and the FICMAE, the gamma-Gompertz
model is selected for females and the Gompertz model is selected for males. Hence, it ap-
pears that unlike other methods, the FICMAE detects mortality deceleration in the female
sample. Figure 4 also supports this finding of a deceleration in the female mortality rates.
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Figure 4: Death rates (on log scale) of French-Canadian females (left) and males (right):
observed death rates (solid-circle), gamma-Gompertz fit (dashed), Gompertz fit
(dotted), and 95%-confidence band for the Gompertz log-hazard (grey).
Table 1: Values of different model selection criteria for the gamma-Gompertz model (GG)
and the Gompertz model using data on French-Canadians.
Females Males
GG Gompertz GG Gompertz
AIC∗ 101390.3 101390.0 48364.10 48363.01
FICMAE : µ = σ2 4.065 6.200 4.316 3.890
FICMAE : µ = [ln h(100)]′′ 0.098 0.149 0.120 0.108
6 Discussion
Motivated by the issue of how mortality deceleration can be assessed at high ages, we
have extended the FIC, as introduced by Claeskens and Hjort (2003), to a non-standard
setting in which we are choosing between two models that differ by one parameter that
takes a value on the boundary of the parameter space if the smaller model is the true
model. We considered two versions of the FIC that aim to minimise the limiting MAE or
MSE of the estimator of the focus, respectively. When targeting the MAE, we obtained
the new model selection criterion FICMAE. When targeting the MSE, the model selection
does not depend on the chosen focus, but a pre-test strategy was defined. In addition, we
presented the new AIC∗, which reduces the bias of the original AIC that occurs when the
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selection concerns a parameter that lies on the boundary of the parameter space in the
narrow model.
The proposed model selection criteria provide new tools for the assessment of mor-
tality deceleration in the framework of the gamma-Gompertz model. While traditional
approaches either have low power to detect mortality deceleration or are not valid in the
presence of boundary-constrained parameters, the methods developed here are adapted to
the non-standard setting. An advantage of the FICMAE is that, by choosing an appropriate
focus parameter, it can be targeted directly at the quantities that reveal mortality decel-
eration. We recommend using as the focus parameter the frailty variance or the second
derivative of the log-hazard at some advanced age. Both potential choices readily translate
into the presence or the absence of mortality deceleration, as the focus parameter takes a
value of zero if there is no deceleration.
The results of our simulation studies indicate that the FICMAE, especially with the
recommended choices of the focus parameter, outperforms the competing approaches of the
pre-test and the AIC∗ in detecting mortality deceleration. This observation was made for
different magnitudes of the frailty variance, and with different sample sizes. We found that
the FICMAE performs substantially better than the AIC∗, particularly for small samples.
Moreover, in contrast to the other methods, the FICMAE detected mortality deceleration
in our sample of female French-Canadian Catholics born at the end of the 19th century. It
therefore appears that using the FICMAE approach can bring new insights into the ongoing
debate about mortality deceleration.
While the set-up in this article was restricted to individual-level data, many studies on
ageing rely on aggregated data in which death counts and exposure times are available
for given age-intervals. However, an extension of the approach to aggregated data is
straightforward if we keep the assumption of the parametric model. Consequently, the
new tools for the assessment of mortality deceleration presented here will be applicable to
a variety of data sets collected for different human and non-human populations. For data
on humans, the application of the Gompertz hazard is well-studied and well-established,
both across time and across populations. For data on non-human species, we might want
to consider relaxing the assumption of a parametric model for the hazard. More research
is needed to understand how more flexible hazard shapes can be incorporated by, for
example, using splines and penalised likelihood.
Although our development of the FICMAE was motivated by the specific problem of
assessing mortality deceleration, the method could be used in a range of other contexts in
which there is a need to choose between parametric models that differ only by one parame-
ter with a boundary constraint, such as when assessing heterogeneity in other proportional
hazards frailty models, or when choosing between a Poisson model and an over-dispersed
negative binomial model. Linear mixed models are another model class where some pa-
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rameters, in that case variance components, are restricted to be non-negative and where
a focused search is useful (Cunen et al., 2019).
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S.1 Computational issues
The maximum likelihood estimates of the parameters of the gamma-Gompertz model are
determined via numerical optimisation in R (R Core Team, 2018). Non-negativity of the
parameter estimates is achieved by maximising the log-likelihood over the log-transformed
parameters. Nevertheless, values of the frailty variance σ2 that are close to zero cause
numerical difficulties. Here, we briefly describe the steps that we took to increase the
numerical stability of the estimation problem.
We maximise the log-likelihood via the R-function nlm(), where we can also supply
the analytic gradient of the objective function. In addition, Taylor expansions of the
log-likelihood and its gradient are used if the current value of σ2 is smaller than 10−5.
The numerically identified maximum σˆ2 might still depend on the starting value that was
provided to the optimisation routine. We therefore recommend running the optimisation
with a number of different starting values for the frailty variance and choosing the fit with
the largest value of the log-likelihood as the final estimate.
For calculating the FICMAE values, we need estimates not only of the model param-
eters, but of the information matrix Jfull. For that purpose, we derive analytically
the matrix H(a, b, σ2) of second-order derivatives of the log-likelihood for the gamma-
Gompertz model, and again use a Taylor expansion if σ2 < 10−5. Jfull is then estimated
as −n−1H(aˆ, bˆ, σˆ2); and κˆ2 is the bottom right element of its inverse.
1Address for correspondence: M. Böhnstedt, Max Planck Institute for Demographic Research, Konrad-
Zuse-Str. 1, 18057 Rostock, Germany
E-mail: boehnstedt@demogr.mpg.de
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S.2 Power of the likelihood ratio test
A likelihood ratio test (LRT) for homogeneity in the gamma-Gompertz model, where
H0 : σ2 = 0 and H1 : σ2 > 0, may have low power to detect mortality deceleration.
To illustrate this property, we summarise the results for two of the scenarios that were
described in Section 4 of the main paper. In particular, we show the extent to which a
smaller underlying frailty variance or a smaller sample size can decrease the power of the
test, which is performed at a significance level of 5%. We also compare the power of the
LRT in a situation in which only individuals who survived beyond age 90 can be studied
to a situation in which observations for individuals who survived beyond age 80 or 85 are
available.
Figure S.1 illustrates how strongly the power of the test is affected by the three features.
The left panel displays the results for scenario S1 (frailty variance σ2 = 0.0625), while the
right panel shows the results for scenario S2 in which the frailty variance was roughly
halved (σ2 = 0.03). Within each panel, we can see the loss in power that occurs if only
individuals who survived beyond age 90 (90+) can be studied, instead of individuals who
survived beyond age 80 (80+) or 85 (85+). For example, in the medium-sized scenario S1,
the power of the LRT decreases by more than 45% if the test is based on the 90+ subset
instead of on the 85+ subset.
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Figure S.1: Power of the LRT at the 5% level to detect mortality deceleration in the
gamma-Gompertz model depending on the age range of the data (left to right:
80+, 85+, or 90+). The depicted scenarios are S1 (left) and S2 (right) with
the sample sizes n90+ = 10,000 (blue-dotted-triangle), n90+ = 20,000 (red-
dashed-cross), and n90+ = 105,000 (black-solid-circle).
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S.3 Local power of the LRT and the pre-test
The local power of the LRT for homogeneity in the gamma-Gompertz model is derived in
Böhnstedt and Gampe (2019). Under the sequence of local alternatives (see eq. (2) in the
main paper), the power of the LRT for H0 : σ2 = 0 at level α based on a gamma-Gompertz
sample of size n can be approximated by
1− Φ
(
Φ−1(1− α)− δ
κ
)
= 1− Φ
(
Φ−1(1− α)−
√
nσ2
κ
)
. (S.1)
The pre-test derived in Section 3.2 of the main paper selects the gamma-Gompertz model
if δˆ/κˆ > 0.8399. Due to δˆ/κˆ d−→ max (0, D/κ), we have P
[
δˆ/κˆ ≤ z
]
≈ Φ (z − δ/κ)1{z≥0}.
As a consequence, the power of the pre-test with critical region δˆ/κˆ > 0.8399 is determined
as
P
[
δˆ
κˆ
> 0.8399
∣∣∣fixed δ] ≈ 1− Φ(0.8399− δ
κ
)
. (S.2)
Comparing (S.2) and (S.1), we find that for large samples, the pre-test has approximately
the same power as the LRT for H0 : σ2 = 0 at level α˜ satisfying Φ−1(1 − α˜) = 0.8399,
which is α˜ = 1− Φ(0.8399) ≈ 0.2005.
S.4 Derivation of FICMAE
The FICMAE of a model with focus estimator µˆ, where
√
n(µˆ − µtrue) d−→ Λ, is derived
as an estimate of E[|Λ|]. For the null model, µˆnull converges to a normal distribution,
Λnull = (Λ0 + ωδ) ∼ N (ωδ, τ20 ). Therefore, E[|Λnull|] is calculated as the expected value of
the folded normal random variable |Λ0 + ωδ|; that is,
E[|Λnull|] = E[|Λ0 + ωδ|] = 2τ0φ
(
ωδ
τ0
)
+ 2ωδ
{
Φ
(
ωδ
τ0
)
− 12
}
. (S.3)
For the full model, we have Λfull = Λ0−ω(D−δ)1{D>0}+ωδ1{D≤0}, with D ∼ N (δ, κ2)
independent of Λ0, such that
E[|Λfull|] = E[|Λfull| | D ≤ 0]P [D ≤ 0] + E[|Λfull| | D > 0]P [D > 0]
= E[|Λ0 + ωδ|]Φ
(
− δ
κ
)
+ E[|Λ0 − ω(D − δ)| | D > 0]Φ
(
δ
κ
)
. (S.4)
The first expectation is the same as (S.3). For the computation of the second expec-
tation, we define the normally distributed random vector X = (Λ0, D)T and its affine
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transformation Y = (Λ0 − ω(D − δ), D)T , which is also normally distributed, with mean
vectors µX = µY = (0, δ)T and covariance matrices
Cov[X] =
(
τ20 0
0 κ2
)
and Cov[Y ] =
(
τ20 + ω2κ2 −ωκ2
−ωκ2 κ2
)
.
Then, E[|Λ0 − ω(D − δ)| | D > 0] can be rewritten as
E[|Y1| | Y2 > 0] = E[Y1 | Y1 > 0, Y2 > 0]P [Y1 > 0, Y2 > 0]
P [Y2 > 0]
+ E[−Y1 | −Y1 ≥ 0, Y2 > 0]P [Y1 ≤ 0, Y2 > 0]
P [Y2 > 0]
. (S.5)
The expected values of one component of a bivariate truncated normal distribution are
more easily found for bivariate normal distributions with zero mean vectors, unit variances,
and possible correlations. Transforming Y into such a normally distributed random vector
Z = ((τ20 +ω2κ2)−1/2Y1, (Y2− δ)/κ)T with covariances −ωκ/
√
τ20 + ω2κ2, and noting that
E[Y1 | Y1 > 0, Y2 > 0] =
√
τ20 + ω2κ2 E
[
Z1
∣∣∣Z1 > 0, Z2 > − δ
κ
]
,
we can apply the results of Tallis (1961) to obtain E[Y1 | Y1 > 0, Y2 > 0] in (S.5) as√
τ20 + ω2κ2
P [Y1 > 0, Y2 > 0]
 1√2piΦ
 δ
κ
·
√
τ20 + ω2κ2
τ0
− ωκ√
τ20 + ω2κ2
φ
(
δ
κ
)
Φ
(
ωδ
τ0
) .
Analogously, E[−Y1 | −Y1 ≥ 0, Y2 > 0] in (S.5) is computed as√
τ20 + ω2κ2
P [Y1 ≤ 0, Y2 > 0]
 1√2piΦ
 δ
κ
·
√
τ20 + ω2κ2
τ0
+ ωκ√
τ20 + ω2κ2
φ
(
δ
κ
)
Φ
(
−ωδ
τ0
) .
Combining these two results, we find that E[|Λ0 − ω(D − δ)| | D > 0] in (S.4) is equal to√
τ20 + ω2κ2
Φ
(
δ
κ
) ·√ 2
pi
Φ
 δ
κ
·
√
τ20 + ω2κ2
τ0
− ωκ
Φ
(
δ
κ
) φ( δ
κ
)
· 2
{
Φ
(
ωδ
τ0
)
− 12
}
. (S.6)
Inserting (S.3) and (S.6) into (S.4) yields the postulated result
E[|Λfull|] =
[
2τ0φ
(
ωδ
τ0
)
+ 2ωδ
{
Φ
(
ωδ
τ0
)
− 12
}]{
1− Φ
(
δ
κ
)}
+
√
τ20 + ω2κ2 ·
√
2
pi
Φ
 δ
κ
·
√
τ20 + ω2κ2
τ0
− ωκφ( δ
κ
)
· 2
{
Φ
(
ωδ
τ0
)
− 12
}
.
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S.5 Other focus parameters
In our simulation studies, we also assessed the performance of the FICMAE for several other
focus parameters, such as quantiles of the survival distribution or the log-hazard and the
survival function at different advanced ages. Overall, the frailty variance, µ = σ2, and the
second derivative of the log-hazard, µ = [ln h(y)]′′, yielded the best results. Figure S.2
illustrates the proportion of decisions in favour of the gamma-Gompertz model in several
settings, when the focus is placed on the second derivative of the log-hazard at age 100,
the log-hazard at age 100 or 110, or the survival function at age 100. While the choice
of µ = [ln h(100)]′′ again results in the highest proportion of decisions in favour of the
gamma-Gompertz model, the choice of µ = S(100) performs almost as well. When the
focus is put on the log-hazard, the age at which the function is evaluated apparently
makes a difference, in that µ = ln h(110) leads to a better performance of the FICMAE
than µ = ln h(100). However, survival beyond age 110 is relatively rare in some of our
simulated settings, and we should be careful when putting the focus on ages for which
there are too few data points.
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Figure S.2: Proportion of decisions in favour of the gamma-Gompertz model based on
FICMAE with µ = [ln h(100)]′′ (black-solid-circle), µ = ln h(100) (grey-dot-
dashed-square), µ = ln h(110) (red-dashed-cross) and µ = S(100) (blue-
dotted-triangle). Left: Decisions in scenario S1 for sample sizes n90+ = 10,000,
n90+ = 20,000 and n90+ = 105,000 (left to right). Right: Decisions in scenarios
S1, S2 and S3 (left to right) all with n90+ = 20,000.
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S.6 Impact of the age range on the performance of the FICMAE
In the main paper, we have, motivated by the data application, considered only samples
of individuals who survived beyond age 90. However, the amount of heterogeneity in
mortality risk within the population decreases with age due to selection. Therefore, it
is of interest to study the performance of the FICMAE according to the age range of the
sample. Figure S.3 depicts the proportion of correct decisions in favour of the gamma-
Gompertz model based on the FICMAE with µ = [ln h(100)]′′ in different settings when
the sample consisted of all individuals who had reached at least age 80, 85, or 90. We
see that, in general, the probability of detecting mortality deceleration increases if the
sample covers a wider age range. For scenario S1 with the target sample size of n90+ =
10,000, the proportion of correct decisions increases by more than a third if we observe
all individuals who had reached at least age 85 instead of only those individuals who had
reached at least age 90. Both the larger sample size of the 85+ subset and the greater
amount of heterogeneity in the mortality risk of this subset played a part in this result.
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Figure S.3: Proportion of correct decisions in favour of the gamma-Gompertz model based
on the FICMAE with µ = [ln h(100)]′′ depending on the age range of the data
(left to right: 80+, 85+, or 90+). The depicted scenarios are S1 (left) and S2
(right) with sample sizes n90+ = 10,000 (blue-dotted-triangle), n90+ = 20,000
(red-dashed-cross) and n90+ = 105,000 (black-solid-circle).
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